Trial Profile
Phase II study of induction therapy: S-1 and cisplatin with concurrent radiation for patient with stage IIA-IIIA locally advanced non-small cell lung cancer.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 16 Feb 2021
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Adenocarcinoma; Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 15 Feb 2021 Status changed from active, no longer recruiting to completed.
- 20 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.